Related references
Note: Only part of the references are listed.Atorvastatin Prevents Early Oxidative Events and Modulates Inflammatory Mediators in the Striatum Following Intranasal 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Administration in Rats
Naiani F. Marques et al.
NEUROTOXICITY RESEARCH (2018)
LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells
Yuan Chen et al.
NEUROTOXICOLOGY (2018)
LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson's disease through stabilizing PINK1 protein
Wang Yan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Interaction and cross-talk between non-coding RNAs
Soichiro Yamamura et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease
Yaohui Ni et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2017)
Altered Long Noncoding RNA Expression Precedes the Course of Parkinson's Disease-a Preliminary Report
Theo F. J. Kraus et al.
MOLECULAR NEUROBIOLOGY (2017)
Inhibition of glycogen synthase kinase-3β reduces ROS production and alters antioxidant enzyme activities in MPP plus -induced neuronal cell death
Guliz Armagan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Candidate novel long noncoding RNAs, MicroRNAs and putative drugs for Parkinson's disease using a robust and efficient genome-wide association study
Zahra Mortezaei et al.
GENOMICS (2017)
Noncoding RNAs in protein clearance pathways: implications in neurodegenerative diseases
Sonali Sengupta
JOURNAL OF GENETICS (2017)
Neuropathology of Genetic Synucleinopathies With Parkinsonism: Review of the Literature
Susanne A. Schneider et al.
MOVEMENT DISORDERS (2017)
MicroRNAs in Parkinson's disease and emerging therapeutic targets
Bridget Martinez et al.
NEURAL REGENERATION RESEARCH (2017)
Mitochondrial ROS-mediated post-transcriptional regulation of α-synuclein through miR-7 and miR-153
Goun Je et al.
NEUROSCIENCE LETTERS (2017)
Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity
Zhao-xiang Ren et al.
ACTA PHARMACOLOGICA SINICA (2016)
MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression
Amrita Datta Chaudhuri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease
Haixia Ding et al.
PARKINSONISM & RELATED DISORDERS (2016)
Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
Mojtaba Golpich et al.
PHARMACOLOGICAL RESEARCH (2015)
The molecular mechanism of rotenone-induced α-synuclein aggregation: Emphasizing the role of the calcium/GSK3β pathway
Yu-he Yuan et al.
TOXICOLOGY LETTERS (2015)
GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein
J. J. Credle et al.
CELL DEATH AND DIFFERENTIATION (2015)
Protective Effects of Salidroside in the MPTP/MPP+-Induced Model of Parkinson's Disease through ROS-NO-Related Mitochondrion Pathway
Songhai Wang et al.
MOLECULAR NEUROBIOLOGY (2015)
Long non-coding RNAs: modulators of nuclear structure and function
Jan H. Bergmann et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
Tat-Fused Recombinant Human SAG Prevents Dopaminergic Neurodegeneration in a MPTP-Induced Parkinson's Disease Model
Eun Jeong Sohn et al.
MOLECULES AND CELLS (2014)
Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.
J. A. Morales-Garcia et al.
ACS CHEMICAL NEUROSCIENCE (2013)
MicroRNAs: Possible role in pathogenesis of Parkinson's disease
E. V. Filatova et al.
BIOCHEMISTRY-MOSCOW (2012)
Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP+, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells
Ju-Xian Song et al.
NEUROSCIENCE LETTERS (2012)
Astaxanthin protects against MPTP/MPP plus -induced mitochondrial dysfunction and ROS production in vivo and in vitro
Dae-Hee Lee et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
MicroRNAs in Parkinson's disease
Maged M. Harraz et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2011)
The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies
Christopher G. Goetz
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
NOX Enzymes in the Central Nervous System: From Signaling to Disease
Silvia Sorce et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Inhibition of glycogen synthase kinase-3 beta protects doparninergic neurons from MPTP toxicity
Wenya Wang et al.
NEUROPHARMACOLOGY (2007)
Share Paper
